Seminars in Oncology
Volume 29, Issue 4 , Pages 382-388, August 2002

European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma☆

Department of Surgical Oncology, Erasmus University Medical Center–Daniel den Hoed Cancer Center, Rotterdam, the Netherlands; and the Department of Medicine, Royal Marsden Hospital, London, UK

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Alexander M.M. Eggermont, MD, PhD, Professor of Surgical Oncology, Department of Surgical Oncology, Erasmus University Medical Center–Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA Rotterdam, the Netherlands.

PII: S0093-7754(02)50268-2

doi:10.1053/sonc.2002.34117

Seminars in Oncology
Volume 29, Issue 4 , Pages 382-388, August 2002

Article Tools